Delivery Order SPE2DE21D7009-SPE2D626F04G2
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,798.00 on November 28, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 5, 2025 and will be performed in Valencia, California. The award was issued by the Medical Supply Chain, a Defense-related procurement entity within the federal government, with no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,825.75 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment authority is performance-based in Valencia, California, and carries an ultimate completion date of December 5, 2025. The contract was awarded by the Medical Supply Chain, a defense-related procurement entity under the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $42,456.67 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment provisions falls under the larger Defense Logistics Agency Troop Support Medical indefinite delivery contract (SPE2DE) valued at $83.1 million and running through August 16, 2026. The award carries no small business set-aside...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE)...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,838.13 for pain management medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on November 28, 2025, with an ultimate completion date of December 17, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division, a defense-related procurement entity supporting the Department of Defense. The...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $49,861.17 on July 14, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of July 25, 2025, and will be performed in Valencia, California. The contract carries no set-aside designation, indicating open competition in the federal marketplace. The funding agency is the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F04G2Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $2,683.75 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 5, 2025. The contract employs fixed-price pricing with economic price adjustment and is issued without a small business set-aside. The work will be performed in Valencia, California, under the Defense Logistics Agency's Medical Supply Chain procurement entity. This delivery order is issued against Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with DLA Troop Support Medical, valued at $83.1 million and extending through August 16, 2026, which provides comprehensive neuromodulation solutions to military treatment facilities and Veterans Affairs medical centers nationwide. Boston Scientific Neuromodulation specializes in non-opioid pain management technologies, including spinal cord stimulation systems such as the RestoreSensor and Spectra WaveWriter devices, implantable pain pumps, radiofrequency ablation equipment, and associated accessories and technical support. The company's core mission focuses on delivering advanced neuromodulation therapies to service members and veterans managing chronic pain resulting from traumatic injuries. As a prime contractor to the Defense Department through the Medical Supply Chain, Boston Scientific Neuromodulation has demonstrated consistent capability in supplying sophisticated medical devices and related services, positioning itself as a critical vendor for the Defense Health Agency's pain management initiatives across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/27/25 |